Back
Daré Bioscience, Inc. 10K Form
Sell
28
DARE
Daré Bioscience, Inc.
Last Price:
$1.78
Seasonality Move:
23.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DARE News And Ratings
See the #1 stock for the next 7 days that we like better than DARE
DARE Financial Statistics
Sales & Book Value
| Annual Sales: | $9.8K |
|---|---|
| Cash Flow: | $-616.8K |
| Price / Cash Flow: | 2.85 |
| Annual Sales: | $0.21 |
| Price / Book: | 8.95 |
Profitability
| EPS (TTM): | -1.78300 |
|---|---|
| Net Income (TTM): | $-16.7M |
| Gross Margin: | $-503.5K |
| Return on Equity: | 0% |
| Return on Assets: | -80.09% |
Daré Bioscience, Inc. Earnings Forecast
Key Daré Bioscience, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for DARE is -5,137.76%.
-
The Selling, General & Administrative Expenses for DARE have been equal to 93,429.59% of Gross Profit Margin.
-
The Research & Development expenses have been 144,951.02% of Revenue.
-
The Net Earning history of DARE is -41,363.27% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 11 years.
Daré Bioscience, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | DARE |
| CUSIP: | 23666P |
| Website: | darebioscience.com |
Debt
| Debt-to-Equity Ratio: | 2.86 |
|---|---|
| Current Ratio: | 1.18 |
| Quick Ratio: | 1.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DARE Technical Analysis vs Fundamental Analysis
Sell
28
Daré Bioscience, Inc. (DARE)
is a Sell
Is Daré Bioscience, Inc. a Buy or a Sell?
-
Daré Bioscience, Inc. stock is rated a SellThe current Daré Bioscience, Inc. [DARE] share price is $1.79. The Score for DARE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.